Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Lactococcus lactis as a delivery system for surface displayed mimotopes of major peanut allergen Ara h 2
ID
Lunder, Mojca
(
Author
),
ID
Luzar, Jernej
(
Author
),
ID
Ključevšek, Tim
(
Author
),
ID
Berlec, Aleš
(
Author
),
ID
Štrukelj, Borut
(
Author
),
ID
Skerbinjek-Kavalar, Maja
(
Author
),
ID
Koren, Ana
(
Author
),
ID
Korošec, Peter
(
Author
)
PDF - Presentation file,
Download
(2,78 MB)
MD5: 163E4CE0313A464645819AA159276AD5
URL - Source URL, Visit
https://www.sciencedirect.com/science/article/pii/S0022175925001218
Image galllery
Abstract
The prevalence of peanut allergy has been steadily increasing over the last decades. Among food allergies it shows the highest severity and is potentially fatal. Allergen Ara h 2 stands out as the main elicitor of allergic reactions. Research in the field of peanut immunotherapy still strives to improve the significant drawbacks of currently approved therapeutics. In this study we tested three epitope-like peptides as epitope-specific treatment. The epitope-like peptides (mimotopes) of major peanut allergen Ara h 2 were expressed as fusions with scaffold protein – lactococcal peptidoglycan binding domain of AcmA. Mimotope-decorated L. lactis and mimotope-AcmA fusion proteins were characterized. The mimotopes retained the ability to bind IgE from peanut-allergic patients' sera. They showed low basophil activation in peanut-allergic patients, except for mimotope DHPRYGP fused to AcmA suggesting its allergenic activity was partially preserved due to the highest similarity with Ara h 2 epitope. Mimotopes fused to AcmA can elicit T cell response; the increased secretion of IFN-γ suggests the shift of T cell immune response to non-allergic type 1. The use of recombinant L. lactis as a delivery system for surface displayed mimotopes represents a promising strategy that would enable delivery and expression of mimotopes on mucosal surfaces and at the same time beneficial immunomodulating properties.
Language:
English
Keywords:
peanut allergy
,
Ara h 2
,
Lactococcus lactis
,
mimotopes
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
8 str.
Numbering:
[article no.] 113921, Vol. 543
PID:
20.500.12556/RUL-175626
UDC:
615.015.14:616-056.43
ISSN on article:
1872-7905
DOI:
10.1016/j.jim.2025.113921
COBISS.SI-ID:
247676163
Publication date in RUL:
06.11.2025
Views:
69
Downloads:
5
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of immunological methods
Publisher:
Elsevier Science
ISSN:
1872-7905
COBISS.SI-ID:
26129113
Licences
License:
CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:
http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:
The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Secondary language
Language:
Slovenian
Keywords:
dostavni sistemi
,
alergeni
,
mimotopi
,
Lactococcus lactis
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0420
Name:
Napredna imunološka zdravila in celični pristopi v farmaciji
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P4-0127
Name:
Farmacevtska biotehnologija: znanost za zdravje
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P3-0360
Name:
Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J3-50099
Name:
Nov terapevtski pristop za zdravljenje alergijskih bolezni, ki temelji na inhibiciji interakcije med epitopi in paratopi
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back